S. Pugh

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

Paul D. Brown, S. Pugh, Nadia N. Laack et al. · Neuro-Oncology · 2013 · 944 citations · Full text

Medicine, Pharmacotherapy, Radiation Oncology +17

Memory Preservation With Conformal Avoidance of the Hippocampus During Whole-Brain Radiation Therapy for Patients With Brain Metastases: Primary Endpoint Results of RTOG 0933

Vinai Gondi, Minesh P. Mehta, S. Pugh et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 63 citations

Medicine, Oncology, Radiation Oncology +16

Radiotherapy (RT) Dose-intensification (DI) Using Intensity-modulated RT (IMRT) versus Standard-dose (SD) RT with Temozolomide (TMZ) in Newly Diagnosed Glioblastoma (GBM): Preliminary Results of NRG Oncology BN001

Vinai Gondi, S. Pugh, C. Tsien et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 54 citations

Medicine, Oncology, Radiation Oncology +15

Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report

Christina Tsien, S. Pugh, Adam P. Dicker et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 50 citations

Medicine, Oncology, Radiation Oncology +17

Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003

Mark K. Buyyounouski, S. Pugh, R.C. Chen et al. · International Journal of Radiation Oncology*Biology*Physics · 2021 · 29 citations · Full text

Medicine, Oncology, Radiation Oncology +15